Missouri doctors will now have to be in the same room as patients when administering Mifepristone, also known as RU-486, or other abortion-inducing drugs.
The state legislature gave final approval to HB 400 this week, requiring that initial dose of any abortion-inducing drug be made in the physical presence of the doctor providing it. The bill also requires that the physician make “all reasonable efforts” to ensure a follow-up visit.
“The passage of HB 400 is a victory for the lives of unborn babies and the health of women in Missouri,” Riddle said in a news release. “It will limit the number of abortions in our state by making it more difficult for abortion clinics to push chemical abortions without having an abortionist on staff at their facility. This legislation will keep accountability and responsibility on doctors to be physically present to offer care both before and after the administering of an abortifacient and not just dole out drugs while sitting behind a computer.”
The bill passed with 115 votes in the House, and won 23 to 7 in the Senate.
The legislature also passed SB 126. Under this bill, sponsored by Sen. David Sater (R-Cassville) Missouri pharmacies cannot be required to carry or maintain an inventory of specific drugs or devices – including abortion-inducing drugs.
Planned Parenthood released a statement denouncing both measures, arguing they are harmful to women. “The Missouri Legislature advanced proposals designed to endanger women's health while failing to expand Medicaid,” the statement said. Paula Gianino and Peter Brownlie, two regional presidents and CEOs of Planned Parenthood, lamented the loss of telemedicine practices for women in rural areas.
Missouri Right to Life applauded the passage of both “pro-life bills” as protecting women and unborn children. “This legislation protects women from those in the abortion industry who seek to profit from RU 486 abortions by providing sub-standard care to women,” Missouri Right to Life President Pam Fichter said in a statement.